Exact Sciences acquires MT's technology
Executive Summary
MT Technologies (formerly Mosaic Technologies; DNA probe diagnostics) has sold Exact Sciences (cancer diagnostics) certain IP assets, including its Hybrigel electrophoresis medium. Exact is paying $1.25mm in cash and issuing warrants to buy 10k of its common shares at $7.33 each (market price at announcement) over the next three years.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
-
Drug Discovery Technologies
- Genomics-Proteomics
-
Drug Discovery Technologies
Deal Status
- Final
Deal Type
-
Alliance
- Intra-Biotech Deal
- Product Purchase
- R&D and Marketing (Licensing)
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice